RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT)

Clinical trials for RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT) explained in plain language.

Never miss a new study

Get alerted when new RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT) trials appear

Sign up with your email to follow new studies for RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Blood test could personalize breast cancer treatment, spare some from extra drugs

Disease control Not yet recruiting

This study is testing a personalized approach for people with intermediate-risk, hormone-positive breast cancer. It uses a special blood test to check for tiny signs of cancer. If the test is positive, patients add a targeted drug (CDK4/6 inhibitor) to their standard hormone ther…

Matched conditions: RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT)

Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT)

Get alerted when new RECEPTORS, ESTROGEN (FOR ER-POSITIVE REQUIREMENT) trials appear

Blood test could personalize breast cancer treatment, spare some from extra drugs